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Type 1 Integrons in Epidemiologically Unrelated
Acinetobacter baumannii Isolates Collected
at Spanish Hospitals
Acinetobacter baumannii is an opportunistic nosocomial
pathogen, which is an important cause of pneumonia and bac-
teremia in patients in intensive care units (1). Increased resis-
tance to all commercial antimicrobial agents, including colistin,
in clinical isolates of A. baumannii has been reported (7, 12).
An important factor for the development of multiresistance is
the acquisition of genetic elements, such as integrons (6). Dif-
ferent reports have been published, identifying integrons as
responsible for the presence and acquisition of antibiotic re-
sistance in members of the genus Acinetobacter (2, 3, 5, 8, 9, 10,
13).
The aim of this study was to investigate the role of type 1
integrons in mediating antibiotic resistance in Spanish clinical
isolates of A. baumannii. Moreover, the epidemiological rela-
tionship between Spanish isolates containing type 1 integrons
and seven isolates from Italian hospitals containing the same
integrons was determined.
For this purpose, 69 epidemiologically unrelated A. bauman-
nii isolates were collected during November 2000 from 28
Spanish hospitals. All isolates were identified by amplified ri-
bosomal DNA restriction analysis (11), and their epidemiolog-
ical relationship was determined by pulsed-field gel electro-
phoresis (PFGE), following the method of Gautom (4).
PCR amplification of type 1 integrons was done using the set
of primers described by Ploy et al. (8) following conditions and
procedures that will be published elsewhere (9). DNA se-
quencing of the inserted gene cassettes was performed with the
dRhodamine terminator cycle sequencing kit and was analyzed
in an automatic DNA sequencer (ABI Prism 377; Perkin-
Elmer, Emeryville, Calif.)
Of a total of 69 A. baumannii isolates, 19 (27.53%) possessed
type 1 integrons. Fifteen of these 19 (78.94%) isolates showed
the presence of a 700-bp band containing a single aadB allele
(Table 1). One of the 19 isolates (5.26%) yielded an amplifi-
cation product of approximately 2,400 bp (Table 1) with three
gene cassettes, an aacA4 allele, an open reading frame (ORF)
coding for a yet undetermined product named OrfO, and the
blaOXA-20 gene (5, 8). Two of the 19 isolates (10.52%) gave an
amplification product of approximately 800 bp (Table 1). Di-
rect sequencing of this amplicon revealed the presence of a
single gene cassette that contained an aacA4 gene, which was
identical to that found in the integron mentioned above. Of the
two isolates containing this integron, one was resistant to both
tobramycin and amikacin, while the other isolate was resistant
to tobramycin but was susceptible to amikacin. These results
agreed with those found by Ploy et al. (8) who found two
isolates with the same integron but susceptible to amikacin.
Only one isolate (5.26%) showed an amplicon of approxi-
mately 2,800 bp containing four gene cassettes (Table 1), an
aacC1 determinant, followed by two ORFs that code for un-
known products and that are carried on two cassettes (5), and
an aadA1a gene. To our knowledge, this type of integron
carrying four gene cassettes has been described only once and
is found in Italian isolates (5).
The integrons of 800, 2,400, and 2,800 bp, were found in
Italian A. baumannii isolates. In order to elucidate whether
Italian isolates with the same type of integrons (5) possessed
the same clonal origin as the Spanish clinical isolates of A.
baumannii, a PFGE was performed. The results showed that
all the isolates were not epidemiologically related.
In conclusion, our results reflect the potential risk of anti-
microbial resistance dissemination, both within and between
unrelated species. Moreover, we demonstrate that nonrelated
isolates from different geographic areas are able to acquire
common integrons, leading to the question of whether A. bau-
mannii has a clear affinity for a specific type of integron.
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TABLE 1. Integron gene composition related to the phenotype of
resistance found in A. baumannii clinical isolates
No. of
isolates
(n  19)
Amplicon
size (bp) Resistance gene(s)
Resistance
phenotypea
15 700 aadB GEN, TOB
1 2,400b aacA4, ORF O, blaOXA-20 AMK,
TOB,
-Lactams
2 800b aacA4 TOB
1 2,800b aacC1, ORF X, ORF X, aadA1a GEN
a Abbreviations: GEN, gentamicin; TOB, tobramycin; AMK, amikacin.
b Gene cassettes found in Italian isolates.
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